Purpose: To compare efficacies of 1-day, 1-hour, and combined 1-day/1-hour preoperative topical gatifloxacin in eliminating conjunctival bacterial flora.

Design: Prospective, comparative case series.

Participants: Sixty patients (120 eyes) scheduled to undergo anterior segment intraocular surgery at Stanford University Medical Center.

Methods: Cultures were collected from the palpebral conjunctival sac at baseline and after 1 day (4 doses), 1 hour (3 doses), and 1 day/1 hour (7 doses) of gatifloxacin use.

Main Outcome Measures: Incidence of positive bacterial samples collected pre- and post-antibiotic treatment and number of colony forming units (CFUs).

Results: SeptiChek (Becton Dickinson, Franklin Lakes, NJ) positive cultures significantly decreased from 67% growth at baseline to 28% (P<0.0001) after 1 day and from 60% at baseline to 37% (P = 0.018) after 1 hour of gatifloxacin use. Reductions of 44% growth at baseline to 12% (P = 0.0001) after 1 day and 32% at baseline to 13% (P = 0.029) after 1 hour of gatifloxacin use were observed on blood agar. Surgical eyes that received both 1-day and 1-hour preoperative gatifloxacin had reductions from 67% growth at baseline to 18% posttreatment (P<0.0001) and 45% at baseline to 7% posttreatment (P<0.0001) on SeptiChek and blood agar media, respectively. In addition to a lower frequency of positive cultures, a significantly lower CFU count was found after 1-day (P = 0.004) and 1-hour (P = 0.049) gatifloxacin use compared with pretreatment levels. Combined 1-day/1-hour doses of gatifloxacin were associated with a greater reduction in CFUs (P = 0.001) when compared with 1-hour treatment alone.

Conclusions: Both 1-hour and 1-day topical gatifloxacin use are effective in reducing the frequency of conjunctival bacterial growth and the overall bacterial load as measured by CFUs, relative to baseline. Although a 1-hour pretreatment is associated with a reduction in bacterial growth, the combination of 1-day and 1-hour preoperative gatifloxacin dosing results in an even lower overall bacterial load, suggesting that the latter might be the preferred preoperative regimen for eyes undergoing anterior segment surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2008.06.024DOI Listing

Publication Analysis

Top Keywords

topical gatifloxacin
8
gatifloxacin eliminating
8
eliminating conjunctival
8
conjunctival bacterial
8
hour doses
8
comparison one-day
4
one-day versus
4
versus one-hour
4
one-hour application
4
application topical
4

Similar Publications

Article Synopsis
  • Bacterial keratitis is a serious eye infection that can lead to corneal inflammation and potentially blindness, but can be treated with topical fluoroquinolones and corticosteroids like Gatifloxacin and Dexamethasone.
  • A new bioanalytical method using tandem mass spectrometry (LC-MS/MS) has been developed to simultaneously measure Gatifloxacin and Dexamethasone, achieving separation in under 5 minutes with high accuracy.
  • The method was validated according to USFDA guidelines and applied successfully in a study analyzing these drugs in rabbit tear fluid after topical application, demonstrating its effectiveness for pharmacokinetic analysis.
View Article and Find Full Text PDF

A Case of Parinaud Oculoglandular Syndrome in Which DNA Was Detected in the Cornea and Conjunctiva by Polymerase Chain Reaction.

Medicina (Kaunas)

August 2024

Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Nagasaki, Japan.

Article Synopsis
  • Parinaud oculoglandular syndrome (POS) is a condition characterized by unilateral eye inflammation and lymphadenopathy, often linked to infections like cat-scratch disease.
  • A 29-year-old man developed POS after adopting a stray cat, experiencing symptoms like fever and eye discharge; tests confirmed the presence of the disease-causing DNA.
  • After two weeks of oral medication and two months of topical treatment, the patient's eye condition improved significantly, highlighting the value of PCR testing in diagnosing ocular infections related to POS.
View Article and Find Full Text PDF

Purpose: To identify the predisposing factors, clinico-microbiological profiles, and treatment responses in patients with atypical mycobacterial keratitis.

Methods: The study retrospectively analyzed patients who presented at a tertiary eyecare center in eastern India with atypical mycobacterial keratitis between 2008 and 2021. The diagnostic criteria included cases positive for acid-fast bacilli on Ziehl-Nielsen stain or culture.

View Article and Find Full Text PDF

Corneal deposits associated with topical medications, particularly fluoroquinolones, are a recognized complication in ophthalmic practice. We present a case of a 66-year-old female with pseudophakic bullous keratopathy who developed corneal crystalline deposits following prolonged use of gatifloxacin and prednisolone eye drops post-penetrating keratoplasty. The patient presented with diminished vision and significant corneal opacity in the affected eye.

View Article and Find Full Text PDF

Scleritis following intravitreal brolucizumab injection: a case series.

J Med Case Rep

February 2024

Department of Ophthalmology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi, 329-0431, Japan.

Background: This study reports the first cases of scleritis following intravitreal brolucizumab (IVBr) injection for nAMD, emphasizing the need to be aware of the possibility of scleritis following IVBr injections.

Case Presentation: Case 1. A 74-year-old Japanese man with nAMD complained of conjunctivitis and decreased vision in the right eye 8 days after his eighth IVBr injection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!